Merck Sterile Product Manufacturing Difficulties Affect Cancidas, Timoptic
Executive Summary
Merck's recently launched antifungal Cancidas is in short supply as a result of manufacturing difficulties affecting the company's sterile product lines
You may also be interested in...
Zocor Manufacturing Efficiencies Reduce Cycle Times By 30%
Merck has reduced Zocor manufacturing cycle times by 30% since 2000 through process improvements and enhanced supply chain management, Manufacturing Division President Richard Clark told analysts
Zocor Manufacturing Efficiencies Reduce Cycle Times By 30%
Merck has reduced Zocor manufacturing cycle times by 30% since 2000 through process improvements and enhanced supply chain management, Manufacturing Division President Richard Clark told analysts
Schering Global Manufacturing Head Boisclair Is 30-Year Merck Veteran
Schering-Plough is turning to its Zetia partner Merck for its new head of global manufacturing, Robert Boisclair